Archive
SHIFT 2024 Summary: Evolving Phenotypes in the Cystic Fibrosis Population
In this summary, we review key points, next steps, and actions arising from the presentations and cross-disciplinary panel discussion held during the SHIFT 2024 symposium (4 August 2024), which considered current knowledge, discussed future trends and explored opportunities to support best-practice care for emerging versus classic CF disease phenotypes in the CFTR modulator era. Read More
Read MoreSHIFT Masterclass: Monitoring Health and Disease Progression in the CFTR Modulator Era
Prepared by A/Prof Tonia Douglas, this SHIFT Masterclass examines clinical challenges and gaps, and underscores opportunities to reconsider how and what we monitor in CF, to ensure it is clinically relevant and supports optimal health outcomes for patients in this new era of CF. These valuable insights were summarised from a comprehensive cross-disciplinary discussion held during Session 4 at SHIFT 2023 (11 November 2023). Read More
Read MoreState-of-the-Art: Monitoring Health and Disease Progression in the CFTR Modulator Era
Prof Daniel Peckham reviews the state-of-the-art for monitoring health and disease progression in the CFTR modulator era. This article is based on presentation given by Prof Peckham at SHIFT 2023, and explores how we must reconsider how and what we monitor in CF, to ensure it is clinically relevant and supports optimal health outcomes for patients in this new era of CF. Read More
Read MoreState-of-the-Art: Outpatient Models of Care in CF
Dr Shivanthan Shanthikumar reviews the state-of-the-art for outpatient models of care in the CFTR modulator era. This article is based on presentation given by Dr Shanthikumar at SHIFT 2023, and explores how we must adapt current outpatient care models to maximise opportunities afforded by digital technology, meet the needs of pwCF across emerging phenotypes and optimise health outcomes. Read More
Read MoreSHIFT Masterclass: Shifting Models of Care for Those Growing Older with CF
Prepared in collaboration with Prof Siobhain Mulrennan (WA, AU), this SHIFT Masterclass delves into the clinical challenges and gaps, and highlights opportunities to address the needs of an aging CF population in the CFTR modulator era. These insights emerged from a comprehensive cross-disciplinary discussion held during Session 1 at SHIFT 2023 (10 November 2023). Read More
Read MoreState-of-the-Art: Shifting Models of Care for Those Growing Older with CF
Prof Scott Bell reviews the state-of-the-art for models of care in the context of he aging CF population in the CFTR modulator era. This article is based on presentations given by Prof Scott Bell and Prof Elizabeth Tullis at SHIFT 2023, and emphasises the importance of identifying and addressing various emerging CF phenotypes while tailoring models of care to meet the needs of all people with CF across the lifespan. Read More
Read MoreSHIFT 2023: Next Steps and Actions Towards Shifting Models of Care in CF – How Do We Get Started?
A summary of next steps and actions towards shifting models of care in CF, arising from the cross-disciplinary panel discussion held following the SHIFT 2023 symposium (17 November 2023). Read More
Read More